δ-opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: Lack of evidence for δ-receptor subtypes

Neuropharmacology

Volumn 36, Issue 1, 1997, Pages 125-133

  Connor, M A ^a   Keir, M J ^a   Henderson, G ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

opioid receptor; receptor subtypes; Ca2+ mobilization; homologous desensitization; SH SY5Y neuroblastoma cells

Indexed keywords

7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NALTRIBEN; OPIATE AGONIST; OPIATE ANTAGONIST; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ANIMALS; CALCIUM; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; OLIGOPEPTIDES; RECEPTORS, OPIOID, DELTA;

EID: 0031049268     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00144-X     Document Type: Article

References (33)

1. Buzas B., Izenwasser S., Portoghese P.S. and Cox B.M. (1994) Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Life Sci. 54: PL101-106.
2. Connor M.A., Henderson G. δ- and μ-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 117:1996;333-340.
3. Connor M.A., Keir M.J., Henderson G. δ-Opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence for receptor subtypes. Analgesia. 1:1995;375-378.
4. Connor M.A., Keir M.J., Henderson G. Desensitization of δ opioid mobilization of intracellular calcium in SH-SY5Y cells. Br. J. Pharmacol. 116:1995;314P.
5. 5]enkephalin as a highly selective ligand for the δ-binding site. Br. J. Pharmacol. 84:1985;927-932.
6. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. natn. Acad. Sci. U.S.A. 86:1989;5188-5192.
7. Evans C.J., Keith D.E. Jr., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
8. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor δ- and μ-subtypes. FEBS Lett. 327:1993;311-314.
9. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
10. Hepworth M., Henderson G. Is there a role for protein kinase A in rapid desensitization of δ-opioid and somatostatin responses in NG108-15 cells? Reg. Peptides. 54:1994;121-122.
11. 6]enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;1069-1075.
12. Kazmi S.M.I., Mishra R.K. Comparative pharmacological properties and functional coupling of μ and δ opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 32:1987;109-1188.
13. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. natn. Acad. Sci. U.S.A. 89:1992;12048-12052.
14. Kramer T.H., Davis P., Hruby V.J., Burks T.F., Porreca F. In vitro potency, affinity, and agonist efficacy of highly selective delta opioid receptor ligands. J. Pharmacol. Exp. Ther. 266:1993;577-584.
15. Laugwitz K.-L., Offerman S.S., Spicher K., Schultz G. μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron. 10:1993;233-242.
16. Law P.Y., Bergsbaken C. Properties of delta opioid receptor in neuroblastoma NSY20: receptor activation and neuroblastoma proliferation. J. Pharmacol. Exp. Ther. 272:1995;322-332.
17. Law P.Y., McGinn T.M., Wick M.J., Erikson L.J., Evans C., Loh H.H. Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density? J. Pharmacol. Exp. Ther. 271:1994;1686-1694.
18. 2]deltorphin II in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;583-587.
19. 2a adenosine receptor-stimulated adenylyl cyclase by μ-, δ1-, and δ2-opioid agonists in rat caudate putamen. J. Neurochem. 65:1995;125-133.
20. 2+ in response to lysylbradykinin and histamine in a cultured human colonic epithelium. Eur. J. Pharmacol. 199:1991;77-91.
21. Portoghese P.S., Sultana M., Takemori A.E. Design of δ opioid receptor antagonists using the message-address concept. J. Med. Chem. 33:1990;1714-1720.
22. Prather P.L., Toai A.W., Law P.Y. μ-opioid and δ-opoid receptor desensitization in undifferentiated SH-SY5Y cells. J. Pharmacol. Exp. Ther. 270:1994;177-184.
23. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:1994;330-334.
24. Seward E., Hammond C., Henderson G. μ-Opioid-receptor-mediated inhibition of the N-type calcium-channel current. Proc. Roy. Soc. Lond. 244(Series B):1991;129-135.
25. Seward E.P., Henderson G., Sadee W. Inhibition of calcium currents by μ and δ opioid receptor activation in differentiated human neuroblastoma cells. Adv. Biosci. 75:1990;181-183.
26. Simonin F., Befort K., Gaveriaux-Ruff C., Matthes H., Nappey V., Lannes B., Micheletti G., Keiffer B. The human δ-opioid receptor: genomic organization, cDNA cloning, functional expression and distribution in human brain. Mol. Pharmacol. 46:1994;1015-1021.
27. Sofuoglu M., Portoghese P.S., Takemori A.E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analogue (NTB) in mice: evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;676-680.
28. Sofuoglu M., Portoghese P.S., Takemori A.E. 7-Benzylidenenaltrexone (BNTX): a selective δ1 opioid receptor antagonist in the mouse spinal cord. Life Sci. 52:1993;769-775.
29. Tang T., Kiang J.G., Cox B.M. Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cell. J. Pharmacol. Exp. Ther. 270:1994;40-46.
30. Toll L., Polgar W.E., Auh J.S. Characterization of the δ receptor subtype in SH-SY5Y neuroblastoma cells. Reg. Peptides. 54:1994;303-304.
31. Traynor J.R., Elliot J. δ-opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol. Sci. 14:1993;84-86.
32. 4]deltorphin with opioid receptor subtypes in vivo. Eur. J. Pharmacol. 252:1994;133-137.
33. Wild K.D., Carlisi V.J., Mosberg H.I., Bowen W.D., Portoghese P.S., Sultana M., Takemori A.E., Hruby V.J., Porreca F. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. J. Pharmacol. Exp. Ther. 264:1993;831-838.